No Data
No Data
No Data
No Data
No Data
Buy Rating Affirmed for CARGO Therapeutics on Robust Trial Progress and Strong Market Potential
TipRanksApr 18 06:57 ET
Express News | CARGO Therapeutics Inc - Board Approved an Increase in Number of Authorized Directors on Board From Six to Seven
Moomoo 24/7Apr 15 16:18 ET
Express News | CARGO Therapeutics Names Kapil Dhingra, M.b.b.s., to Board of Directors
Moomoo 24/7Apr 15 16:05 ET
CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors
CARGO Therapeutics, Inc. (Nasdaq: CRGX) today announced it has appointed Kapil Dhingra, M.B.B.S., to the Company's Board of Directors. Dr. Dhingra is a medical oncologist and a physician-scientist bringing more than 25 years of strategic clinical development experience in oncology, including cell therapy, with a proven track record in drug development, patient care and academic research.
GlobeNewswireApr 15 16:05 ET
Express News | CARGO Therapeutics Shares Are Trading Higher. The Company Reported Q4 Financial Results
Moomoo 24/7Mar 22 10:59 ET
Cargo Therapeutics Reports Q4 Net Loss
Cargo Therapeutics (CRGX), which went public in November, reported late Thursday a Q4 net loss of $1.49 per diluted share. Three analysts polled by Capital IQ expected a loss of $1.62 per share. As ex
MT NewswiresMar 22 03:51 ET
No Data
No Data